drugset / Trial / NCT06771128

Ginkgo Biloba vs Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis

NCT06771128

Completed 398 enrolled Menoufia University
RandomizedParallel-groupTriple-blindTreatment

Summary

the efficacy of Ginkgo Biloba versus desmopressin in treatment of children with monosymptomatic nocturnal enuresis

Timeline

Start
2024-11-01
Primary completion
2025-12-01
Completion
2026-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Desmopressin Peptide 0.2 mg Oral
Subject Ginkgo Biloba Extract Traditional medicine (herbal / TCM) 120 mg Oral

Indications